In line herewith, in a similar STZ‐induced type 1 diabetes rat model Liraglutide was shown to normalise DM‐induced myocardial NAD(P)H oxidase activity, oxidative stress markers and apoptosis, without affecting plasma glucose and insulin levels.27, 28. This evidence concerns the gene INS and diabetes mellitus.